Literature DB >> 7111669

Infection and immunosuppression. A study of the infective complications of 75 patients with immunologically-mediated disease.

J Cohen, A J Pinching, A J Rees, D K Peters.   

Abstract

We have studied the infective complications in a group of 75 patients with immunologically-mediated disease who required high dose immunosuppression. There were 22 patients with anti-glomerular basement membrane antibody disease, 19 patients with systemic lupus erythematosus, 18 with wegener's granulomatosis and 16 patients with other forms of systemic vasculitis. The infection rate was 3.69 infections/patient, or 0.74 infections/patient/week of immunosuppression. Bacteria were the commonest infecting organisms (76.1 per cent); serious opportunist viral and fungal infections were less frequent (10.7 per cent) but opportunist pneumonias were an important cause of death. Sixteen patients died (21 per cent) and in 10 of these (62.5 per cent) death was considered to be primarily due to infection. Analysis of six aspects of host susceptibility to infection (age, renal function, dose of prednisolone, cyclophosphamide and azathioprine, and number of plasma exchanges) revealed no single factor as predisposing to infection in the whole group, but in 23 patients who suffered severe infective complications, renal impairment and increasing doses of prednisolone were associated significantly, particularly in combination (p = 0.06). Cyclophosphamide was associated with infection only in the presence of neutropenia, which was rare (13 infections in nine patients). The duration of plasma exchange was not related to the frequency of infection. Fifty patients needed an arteriovenous shunt to provide vascular access for haemodialysis or plasma exchange, and septicaemia occurred in 13; only two episodes of septicaemia were seen in patients without a shunt.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7111669

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  17 in total

Review 1.  Clinical management and treatment of vasculitis.

Authors:  D Jayne
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

Review 3.  ANCA-associated vasculitis: diagnosis and treatment in the elderly.

Authors:  R Parry; S Sherwin; V Fletcher; P Medcalf
Journal:  Postgrad Med J       Date:  1996-07       Impact factor: 2.401

4.  Nocardia asteroides infection of the cauda equina.

Authors:  S J Brecker; C D Pugey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

Review 5.  Intravenous immunoglobulin for secondary immunodeficiency.

Authors:  P L Yap
Journal:  Blut       Date:  1990-01

Review 6.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.

Authors:  Rémi Goupil; Soumeya Brachemi; Annie-Claire Nadeau-Fredette; Clément Déziel; Yves Troyanov; Valery Lavergne; Stéphan Troyanov
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 8.237

8.  Bacteraemia due to recurrent reinfection with Staphylococcus epidermidis associated with defective opsonisation and procidin function in serum.

Authors:  L R Baker; A L Brown; J R Stephenson; S Tabaqchali; M Zatouroff; J M Parkin; A J Pinching
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

9.  Visceral leishmaniasis mimicking a flare of systemic lupus erythematosus.

Authors:  J Braun; J Sieper; K L Schulte; E Thiel; K Janitschke
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

10.  Mycobacterium avium-intracellulare infection presenting as a testicular mass in an immunocompromised patient: a case report.

Authors:  Ruth A Hartley
Journal:  Cases J       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.